We observed that both single treatments independently inhibited initial tumor growth with similar efficacy, while the combinatory regimen induced a slightly better inhibition of tumor growth than anti-PD-1 monotherapy (figure 5B, C). This evidence concerns the gene PDCD1 and neoplasm.